Jim Simons Regenxbio Inc. Transaction History

Renaissance Technologies LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$12.17 - $24.61 $948,043 - $1.92 Million	77,900 Added 397.45%	97,500 $2.05 Million
Q4 2023 Feb 13, 2024	BUY	$12.89 - $20.82 $252,644 - $408,072	19,600 New	19,600 $352,000
Q2 2023 Aug 11, 2023	BUY	$17.23 - $21.71 $477,271 - $601,367	27,700 New	27,700 $554,000
Q2 2021 Aug 13, 2021	SELL	$32.46 - $40.48 $2.14 Million - $2.66 Million	-65,779 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$33.61 - $49.95 $2.21 Million - $3.29 Million	65,779 New	65,779 $2.24 Million
Q3 2019 Nov 13, 2019	SELL	$31.84 - $50.88 $11.2 Million - $17.8 Million	-350,441 Closed	0 $0
Q2 2019 Aug 12, 2019	SELL	$42.0 - $59.29 $21.8 Million - $30.8 Million	-519,300 Reduced 59.71%	350,441 $18 Million
Q1 2019 May 14, 2019	SELL	$40.82 - $62.45 $620,545 - $949,364	-15,202 Reduced 1.72%	869,741 $49.8 Million
Q4 2018 Feb 13, 2019	BUY	$39.11 - $75.15 $34.6 Million - $66.5 Million	884,943 New	884,943 $37.1 Million

197

43.2M

104K

478K

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $439M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.